136 related articles for article (PubMed ID: 2644137)
1. Degradation of insulin and insulin-like growth factors by enzyme purified from human erythrocytes. Comparison of degradation products observed with A14- and B26-[125I]monoiodoinsulin.
Misbin RI; Almira EC
Diabetes; 1989 Feb; 38(2):152-8. PubMed ID: 2644137
[TBL] [Abstract][Full Text] [Related]
2. Characterization of an intracellular insulin-degrading enzyme in human erythrocytes.
Gambhir KK; Nerurkar SG
Biochem Med Metab Biol; 1988 Jun; 39(3):284-9. PubMed ID: 3293635
[TBL] [Abstract][Full Text] [Related]
3. Purification to homogeneity of an insulin-degrading enzyme from human erythrocytes.
Kolb HJ; Standl E
Hoppe Seylers Z Physiol Chem; 1980 Jul; 361(7):1029-39. PubMed ID: 6997171
[TBL] [Abstract][Full Text] [Related]
4. The degradation of monoiodotyrosyl insulin isomers by insulin protease.
Ryan MP; Peavy DE; Frank BH; Duckworth WC
Endocrinology; 1984 Aug; 115(2):591-9. PubMed ID: 6378594
[TBL] [Abstract][Full Text] [Related]
5. Degradation of insulin-like growth factors I and II by a human insulin degrading enzyme.
Roth RA; Mesirow ML; Yokono K; Baba S
Endocr Res; 1984; 10(2):101-12. PubMed ID: 6389104
[TBL] [Abstract][Full Text] [Related]
6. Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies.
Clot JP; Janicot M; Fouque F; Desbuquois B; Haumont PY; Lederer F
Mol Cell Endocrinol; 1990 Sep; 72(3):175-85. PubMed ID: 2289630
[TBL] [Abstract][Full Text] [Related]
7. Identification of radioactive insulin fragments liberated by insulin proteinase during the degradation of semisynthetic [3H]GlyA1]insulin and [3H]PheB1]insulin.
Davies JG; Muir AV; Rose K; Offord RE
Biochem J; 1988 Jan; 249(1):209-14. PubMed ID: 3277617
[TBL] [Abstract][Full Text] [Related]
8. Tyrosine A14[125I]monoiodoinsulin: Preparation, Biologic Properties, and long-term stability.
Linde S; Hansen B; Sonne O; Holst JJ; Gliemann J
Diabetes; 1981 Jan; 30(1):1-8. PubMed ID: 7014299
[TBL] [Abstract][Full Text] [Related]
9. Drosophila insulin degrading enzyme and rat skeletal muscle insulin protease cleave insulin at similar sites.
Duckworth WC; Garcia JV; Liepnieks JJ; Hamel FG; Hermodson MA; Frank BH; Rosner MR
Biochemistry; 1989 Mar; 28(6):2471-7. PubMed ID: 2659071
[TBL] [Abstract][Full Text] [Related]
10. 125I-insulin metabolism by rat liver cells: preferential binding and degradation of insulin labeled at TyrA14.
Misbin RI; Buynitzky SJ; Almira EC
Drug Metab Dispos; 1982; 10(2):153-5. PubMed ID: 6124401
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of insulin degradation by insulin-like growth factors.
Misbin RI; Almira EC; Duckworth WC; Mehl TD
Endocrinology; 1983 Oct; 113(4):1525-7. PubMed ID: 6352249
[TBL] [Abstract][Full Text] [Related]
12. Identification of insulin intermediates and sites of cleavage of native insulin by insulin protease from human fibroblasts.
Stentz FB; Kitabchi AE; Schilling JW; Schronk LR; Seyer JM
J Biol Chem; 1989 Dec; 264(34):20275-82. PubMed ID: 2684974
[TBL] [Abstract][Full Text] [Related]
13. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin.
Duckworth WC; Hamel FG; Bennett R; Ryan MP; Roth RA
J Biol Chem; 1990 Feb; 265(5):2984-7. PubMed ID: 1689296
[TBL] [Abstract][Full Text] [Related]
14. Degradation of insulin by isolated rat renal cortical endosomes.
Fawcett J; Rabkin R
Endocrinology; 1993 Oct; 133(4):1539-47. PubMed ID: 8404592
[TBL] [Abstract][Full Text] [Related]
15. [125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation.
Williams FG; Johnson DE; Bauer GE
Metabolism; 1990 Mar; 39(3):231-41. PubMed ID: 2407925
[TBL] [Abstract][Full Text] [Related]
16. High performance liquid chromatographic analysis of insulin degradation products from a cultured kidney cell line.
Duckworth WC; Hamel FG; Liepnieks J; Frank BH; Yagil C; Rabkin R
Endocrinology; 1988 Dec; 123(6):2701-8. PubMed ID: 3058457
[TBL] [Abstract][Full Text] [Related]
17. Degradation of insulin by insulin-degrading enzyme and biological characteristics of its fragments.
Yonezawa K; Yokono K; Yaso S; Hari J; Amano K; Kawase Y; Sakamoto T; Shii K; Imamura Y; Baba S
Endocrinology; 1986 May; 118(5):1989-96. PubMed ID: 3516656
[TBL] [Abstract][Full Text] [Related]
18. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.
Hardouin S; Gourmelen M; Noguiez P; Seurin D; Roghani M; Le Bouc Y; Povoa G; Merimee TJ; Hossenlopp P; Binoux M
J Clin Endocrinol Metab; 1989 Dec; 69(6):1291-301. PubMed ID: 2555386
[TBL] [Abstract][Full Text] [Related]
19. Sheep insulin-like growth factors I and II: sequences, activities and assays.
Francis GL; McNeil KA; Wallace JC; Ballard FJ; Owens PC
Endocrinology; 1989 Mar; 124(3):1173-83. PubMed ID: 2537174
[TBL] [Abstract][Full Text] [Related]
20. Insulin-degrading enzyme is capable of degrading receptor-bound insulin.
Yonezawa K; Yokono K; Shii K; Hari J; Yaso S; Amano K; Sakamoto T; Kawase Y; Akiyama H; Nagata M
Biochem Biophys Res Commun; 1988 Jan; 150(2):605-14. PubMed ID: 3277630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
